225 related articles for article (PubMed ID: 24561119)
21. Wnt signaling pathway in non-small cell lung cancer.
Stewart DJ
J Natl Cancer Inst; 2014 Jan; 106(1):djt356. PubMed ID: 24309006
[TBL] [Abstract][Full Text] [Related]
22. HOTAIR, a prognostic factor in esophageal squamous cell carcinoma, inhibits WIF-1 expression and activates Wnt pathway.
Ge XS; Ma HJ; Zheng XH; Ruan HL; Liao XY; Xue WQ; Chen YB; Zhang Y; Jia WH
Cancer Sci; 2013 Dec; 104(12):1675-82. PubMed ID: 24118380
[TBL] [Abstract][Full Text] [Related]
23. Wnt inhibitory factor-1 gene transfer inhibits melanoma cell growth.
Lin YC; You L; Xu Z; He B; Yang CT; Chen JK; Mikami I; Clément G; Shi Y; Kuchenbecker K; Okamoto J; Kashani-Sabet M; Jablons DM
Hum Gene Ther; 2007 Apr; 18(4):379-86. PubMed ID: 17472570
[TBL] [Abstract][Full Text] [Related]
24. Does Wnt/β-catenin pathway contribute to the stability of DNMT1 expression in urological cancer cell lines?
Varol N; Konac E; Bilen CY
Exp Biol Med (Maywood); 2015 May; 240(5):624-30. PubMed ID: 25349215
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of Wnt signaling downregulates Akt activity and induces chemosensitivity in PTEN-mutated prostate cancer cells.
Ohigashi T; Mizuno R; Nakashima J; Marumo K; Murai M
Prostate; 2005 Jan; 62(1):61-8. PubMed ID: 15389810
[TBL] [Abstract][Full Text] [Related]
26. Loss of WIF-1 and Wnt5a expression is related to aggressiveness of sporadic breast cancer in Tunisian patients.
Trifa F; Karray-Chouayekh S; Jmal E; Jmaa ZB; Khabir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
Tumour Biol; 2013 Jun; 34(3):1625-33. PubMed ID: 23417837
[TBL] [Abstract][Full Text] [Related]
27. Aberrant promoter methylation of WIF-1 and SFRP1, 2, 4 genes in mesothelioma.
Kohno H; Amatya VJ; Takeshima Y; Kushitani K; Hattori N; Kohno N; Inai K
Oncol Rep; 2010 Aug; 24(2):423-31. PubMed ID: 20596629
[TBL] [Abstract][Full Text] [Related]
28. The hypomethylation agent bisdemethoxycurcumin acts on the WIF-1 promoter, inhibits the canonical Wnt pathway and induces apoptosis in human non-small-cell lung cancer.
Liu YL; Yang HP; Zhou XD; Gong L; Tang CL; Wang HJ
Curr Cancer Drug Targets; 2011 Nov; 11(9):1098-110. PubMed ID: 21933103
[TBL] [Abstract][Full Text] [Related]
29. [Role of NGX6 in Wnt/β-catenin signaling pathway in colon cancer].
Liu F; Sheng S; Wang X; Peng Y; Guo Q; Xiao Z; Liu J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 36(3):235-42. PubMed ID: 21464545
[TBL] [Abstract][Full Text] [Related]
30. Deregulation of Wnt/β-catenin signaling through genetic or epigenetic alterations in human neuroendocrine tumors.
Kim JT; Li J; Jang ER; Gulhati P; Rychahou PG; Napier DL; Wang C; Weiss HL; Lee EY; Anthony L; Townsend CM; Liu C; Evers BM
Carcinogenesis; 2013 May; 34(5):953-61. PubMed ID: 23354304
[TBL] [Abstract][Full Text] [Related]
31. Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer.
Mazieres J; He B; You L; Xu Z; Lee AY; Mikami I; Reguart N; Rosell R; McCormick F; Jablons DM
Cancer Res; 2004 Jul; 64(14):4717-20. PubMed ID: 15256437
[TBL] [Abstract][Full Text] [Related]
32. Wnt signaling activation and WIF-1 silencing in nasopharyngeal cancer cell lines.
Lin YC; You L; Xu Z; He B; Mikami I; Thung E; Chou J; Kuchenbecker K; Kim J; Raz D; Yang CT; Chen JK; Jablons DM
Biochem Biophys Res Commun; 2006 Mar; 341(2):635-40. PubMed ID: 16427602
[TBL] [Abstract][Full Text] [Related]
33. Artificially accumulated beta-catenin inhibits proliferation and induces neurite extension of neuroblastoma cell line NB-1 via up-regulation of trkA.
Sangkhathat S; Nara K; Kusafuka T; Yoneda A; Fukuzawa M
Oncol Rep; 2006 Dec; 16(6):1197-203. PubMed ID: 17089037
[TBL] [Abstract][Full Text] [Related]
34. Cloning and characterization of the promoter of human Wnt inhibitory factor-1.
Reguart N; He B; Xu Z; You L; Lee AY; Mazieres J; Mikami I; Batra S; Rosell R; McCormick F; Jablons DM
Biochem Biophys Res Commun; 2004 Oct; 323(1):229-34. PubMed ID: 15351726
[TBL] [Abstract][Full Text] [Related]
35. The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway.
Flahaut M; Meier R; Coulon A; Nardou KA; Niggli FK; Martinet D; Beckmann JS; Joseph JM; Mühlethaler-Mottet A; Gross N
Oncogene; 2009 Jun; 28(23):2245-56. PubMed ID: 19421142
[TBL] [Abstract][Full Text] [Related]
36. DNA methyltransferase inhibitor-mediated apoptosis in the Wnt/β-catenin signal pathway in a renal cell carcinoma cell line.
Konac E; Varol N; Yilmaz A; Menevse S; Sozen S
Exp Biol Med (Maywood); 2013 Sep; 238(9):1009-16. PubMed ID: 23975733
[TBL] [Abstract][Full Text] [Related]
37. Role of Wnt inhibitory factor-1 and Wnt/wingless signaling in choroid plexus tumors.
Tomm M; Koch A; Mertsch S; Wrede B; Jeibmann A; Wolff J; Paulus W; Hasselblatt M
Pediatr Blood Cancer; 2009 Dec; 53(6):1152-5. PubMed ID: 19621428
[TBL] [Abstract][Full Text] [Related]
38. Rescued expression of WIF-1 in gallbladder cancer inhibits tumor growth and induces tumor cell apoptosis with altered expression of proteins.
Huang Y; Du Q; Wu W; She F; Chen Y
Mol Med Rep; 2016 Sep; 14(3):2573-81. PubMed ID: 27430608
[TBL] [Abstract][Full Text] [Related]
39. MiR-374a Activates Wnt/β-Catenin Signaling to Promote Osteosarcoma Cell Migration by Targeting WIF-1.
Li W; Meng Z; Zou T; Wang G; Su Y; Yao S; Sun X
Pathol Oncol Res; 2020 Jan; 26(1):533-539. PubMed ID: 30523602
[TBL] [Abstract][Full Text] [Related]
40. The Wnt antagonist Wif-1 interacts with CTGF and inhibits CTGF activity.
Surmann-Schmitt C; Sasaki T; Hattori T; Eitzinger N; Schett G; von der Mark K; Stock M
J Cell Physiol; 2012 May; 227(5):2207-16. PubMed ID: 21928342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
